In vitro platforms representing tumor complexity for target validation and drug discovery

被引:0
|
作者
Hickman, John A. [1 ]
机构
[1] Innovat Med Initiat, Paris, France
关键词
D O I
10.1158/1538-7445.AM2013-5529
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5529
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Drug discovery and target validation
    Nuttall, ME
    CELLS TISSUES ORGANS, 2001, 169 (03) : 265 - 271
  • [2] An omics perspective on drug target discovery platforms
    Paananen, Jussi
    Fortino, Vittorio
    BRIEFINGS IN BIOINFORMATICS, 2020, 21 (06) : 1937 - 1953
  • [3] PREDECT: in vitro models for target validation that may better represent tumor complexity
    Hickman, J. A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 73 - 74
  • [4] Target validation: A door to drug discovery
    Chen, Xiu-Ping
    Du, Guan-Hua
    DRUG DISCOVERIES AND THERAPEUTICS, 2007, 1 (01): : 23 - 29
  • [5] Target validation and drug discovery: An overview.
    Kallick, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U470 - U470
  • [6] SiRNAs in drug discovery: Target validation and beyond
    Natt, Francois
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2007, 9 (03) : 242 - 247
  • [7] The importance of target validation in drug discovery and development
    Lowe, John A.
    Jones, Phil
    Wilson, David M.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (05) : 581 - 584
  • [8] Genetically engineered human tumor cells as models for target validation and drug discovery.
    Finney, RE
    Lofquist, A
    Hagios, C
    Wang, N
    Ardourel, D
    Gurgel, J
    Balantac, N
    Calavetta, L
    Girard, E
    Rosler, R
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6127S - 6127S
  • [9] Peptide nanotechnology: Applications in target validation and drug discovery
    Woodman, R
    Ferrigno, PK
    BRITISH JOURNAL OF CANCER, 2002, 86 : S118 - S118
  • [10] Target identification and validation in drug discovery: the role of proteomics
    Kopec, KK
    Bozyczko-Coyne, D
    Williams, M
    BIOCHEMICAL PHARMACOLOGY, 2005, 69 (08) : 1133 - 1139